DLB — Dolby Laboratories Income Statement
0.000.00%
Last trade - 00:00- $6.45bn
- $5.76bn
- $1.35bn
- 94
- 49
- 66
- 80
Annual income statement for Dolby Laboratories, fiscal year end - September 26th, USD millions except per share, conversion factor applied.
2021 September 24th | 2022 September 30th | 2023 September 29th | 2024 September 27th | 2025 September 26th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,281 | 1,254 | 1,300 | 1,274 | 1,349 |
| Cost of Revenue | |||||
| Gross Profit | 1,151 | 1,112 | 1,147 | 1,133 | 1,189 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 937 | 1,047 | 1,084 | 1,015 | 1,084 |
| Operating Profit | 344 | 207 | 216 | 258 | 265 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 355 | 215 | 250 | 312 | 303 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 318 | 184 | 202 | 264 | 256 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 310 | 184 | 201 | 262 | 255 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 310 | 184 | 201 | 262 | 255 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.93 | 1.89 | 2.44 | 2.75 | 2.75 |
| Dividends per Share |